Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Nov. 02, 2025	Nov. 03, 2024
OPERATING ACTIVITIES
Net income	$ 183.6	$ 441.3
Adjustments to reconcile to net cash provided by operating activities:
Depreciation and amortization	205.8	211.6
Equity in net income of unconsolidated affiliates	(32.7)	(34.7)
Deferred taxes	(369.5)	(11.9)
Stock-based compensation expense	37.0	39.1
Impairment of goodwill and other intangible assets	479.5	0.0
Other gain	0.0	(19.5)
Changes in operating assets and liabilities:
Trade receivables, net	(210.4)	(186.6)
Other receivables	4.1	(1.2)
Inventories, net	(80.7)	(188.2)
Accounts payable, accrued expenses and deferred revenue	(169.7)	(0.9)
Prepaid expenses	(18.7)	16.2
Other, net	68.9	(10.8)
Net cash provided by operating activities	97.2	254.4
INVESTING ACTIVITIES
Purchases of property, plant and equipment	(98.5)	(115.4)
Proceeds from sale of Warner's, Olga and True&Co. women's intimates businesses	2.5	5.0
Purchases of investments held in rabbi trust	(9.5)	(4.1)
Proceeds from investments held in rabbi trust	5.2	0.9
Proceeds from cross-currency swap contracts (net investment hedges)	0.0	3.5
Proceeds from sale of warehouse and distribution center	0.0	9.5
Net cash used by investing activities	(100.3)	(100.6)
FINANCING ACTIVITIES
Repayment of 2022 facilities	(9.4)	(9.0)
Net proceeds from settlement of awards under stock plans	1.4	7.3
Proceeds from senior notes, net of related fees	494.0	553.1
Repayment/redemption of senior notes	(500.0)	(561.7)
Cash dividends	(5.7)	(6.4)
Acquisition of treasury shares	(577.2)	(280.2)
Payments of finance lease liabilities	(2.3)	(3.1)
Net cash used by financing activities	(599.2)	(300.0)
Effect of exchange rate on cash and cash equivalents	12.5	(1.8)
Decrease in cash and cash equivalents	(589.8)	(148.0)
Cash and cash equivalents at beginning of period	748.0	707.6
Cash and cash equivalents at end of period	$ 158.2	$ 559.6